Human complement in the arachidonic acid transformation pathway in platelets.
Open Access
- 1 February 1981
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 153 (2) , 257-268
- https://doi.org/10.1084/jem.153.2.257
Abstract
Arachidonate-mediated release of 14C serotonin and thromboxane B2 (TXB2) is significantly enhanced in the presence of complement. Only purified complement components C5, C6, C7, C8, and C9 are required for this reactivity. No known activating mechanism of the classical or alternative pathway is required, nor is C3. In the absence of exogenously added complement, platelet membrane-bound complement components play an essential role in modulating arachidonate-mediated serotonin release. Incubation of platelet membranes with arachidonate and C5--C9 led to the production of dimers of the membrane attack complex (C5b--9) on the platelet surface. These macromolecular complexes were eluted from the platelet membrane and were identified physicochemically and morphologically. The possibility arises that C3 in association with C5--C9 is required for mobilization of the arachidonic acid from the phospholipid of the platelet membrane. Once the arachidonic acid is mobilized, C3 is no longer required, C5--C9 being sufficient to modulate this pathway leading to enhanced production of TXB2.This publication has 24 references indexed in Scilit:
- Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.The Journal of Experimental Medicine, 1979
- C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.The Journal of Experimental Medicine, 1979
- The human complement system in thrombin-mediated platelet function.The Journal of Experimental Medicine, 1978
- Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury.The Journal of Experimental Medicine, 1975
- Subcellular platelet factor VIII antigen and von Willebrand factor.The Journal of Experimental Medicine, 1975
- Additional studies on human C5: Development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresisImmunochemistry, 1972
- THE EIGHTH COMPONENT OF HUMAN COMPLEMENT (C8): ISOLATION, CHARACTERIZATION, AND HEMOLYTIC EFFICIENCYThe Journal of Experimental Medicine, 1969
- A Method of Trace Iodination of Proteins for Immunologic StudiesInternational Archives of Allergy and Immunology, 1966
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965
- ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1963